Recent Quotes (30 days)

You have no recent quotes
chg | %

Vivione Biosciences Inc  

(Public, CVE:VBI)   Watch this stock  
Find more results for VBI
0.195
+0.050 (34.48%)
Mar 4 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.19 - 0.19
52 week 0.14 - 0.44
Open 0.19
Vol / Avg. 1,000.00/8,417.00
Mkt cap 7.70M
P/E     -
Div/yield     -
EPS -0.06
Shares 39.62M
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -3005.07% -1003.06%
Operating margin -3089.15% -725.09%
EBITD margin - -696.37%
Return on average assets -144.80% -174.75%
Return on average equity -621.33% -314.12%
CDP Score - -

Address

34-161 Hoadley Road Pine Bluff Arsenal,Pine Bluff
ARKANSAS CITY, AR 71602
United States - Map
+1-214-8865733 (Phone)
+1-509-5617287 (Fax)

Website links

Description

Vivione Biosciences Inc, formerly Pacepartners Inc, is a life sciences diagnostic company. The Company collaborated with the Food and Drug Administration's National Center for Toxicological Research (NCTR) to develop RAPID-B. The Company's RAPID-B system provides for the rapid detection of bacterial pathogens applicable to the food safety, clinical diagnostics and other markets including agricultural, water testing, pharmaceutical, and medical device applications. The Company's business is centered on the commercialization of the new ultra high performance RAPID-B, an integrated diagnostic system consisting of hardware, software and wetware that tests bacteria in key environments and provides test results in seven hours or less, including sample preparation.

Officers and directors

Kevin Kuykendall Chief Executive Officer, Director
Chester J. Jachimiec Chief Financial Officer, Corporate Secretary
Age: 56
Philip A. Tuttle Director
Age: 70
Ian E. Gallie Independent Director
Age: 57
Lal Narang Independent Director
Age: 74